Search

Harry H Miao

from Redondo Beach, CA
Age ~61
Get Report
Also known as:
Harry Huaquan Miao, Hua Q Miao, Huaquan Q Miao, Huaguan Miao, Quan Miao Huaquan
Connected to:
Anthony A Miao, 33April Miao, 56Chun L Miao, 49Chunlin Miao, 45Eva X Miao, 49Gong Miao, 31Hua F Miao, 56Jacky Miao, 44Jane C Miao, 68Karen Miao, 48

Harry Miao Phones & Addresses

  • Redondo Beach, CA
  • Watertown, MA
  • Cambridge, MA
    • s
  • 121 Tremont St #1, Brighton, MA 02135
  • Boston, MA
  • Edison, NJ
  • Wellesley, MA
  • Brookline, MA
  • New York, NY
  • Hoboken, NJ

Business Records

Name / Title
Company / Classification
Phones & Addresses
Harry Miao
Manager
SHELEI, LC
11 Shadow Ln 11 Shadow Ln, Wellesley, MA 02482
11 Shadow Ln, Wellesley, MA

Publications

Us Patents

Methods For Treating Cancer And Non-Neoplastic Conditions

View page
US Patent:
20120202763, Aug 9, 2012
Filed:
May 27, 2010
Appl. No.:
13/321257
Inventors:
Neil Almstead - Princeton NJ, US
Tamil Arasu - Edison NJ, US
Soongyu Choi - Skillman NJ, US
Jeffrey Allen Campbelll - Hilton Head Island SC, US
Donald Corson - Erie CO, US
Thomas W. Davis - South Orange NJ, US
Jason D. Graci - Scranton PA, US
Zhengxian Gu - Princeton NJ, US
Peter Seong Woo Hwang - Edison NJ, US
William Lennox - Bedminster NJ, US
Harry H. Miao - Wellesley MA, US
Langdon Miller - Seatle WA, US
Young-Choon Moon - Belle Mead NJ, US
Hongyan Qi - Plainsboro NJ, US
Christopher Trotta - Somerset NJ, US
Marla L. Weetall - Morristown NJ, US
Assignee:
PTC THERAPEUTICS, INC - South Plainfield NJ
International Classification:
A61K 31/437
A61K 31/496
A61K 31/5377
A61K 31/506
A61K 31/541
A61K 31/53
A61K 31/497
A61P 35/00
A61P 31/12
A61P 19/02
A61P 37/00
A61P 3/04
A61P 17/06
A61P 9/10
A61P 27/02
A61P 27/06
A61P 27/14
A61P 3/02
A61P 29/00
A61P 11/00
A61P 13/12
A61P 9/12
A61P 17/02
A61P 1/04
A61P 31/22
A61P 33/02
A61P 17/12
A61P 9/00
A61P 7/06
A61P 19/04
A61P 31/04
A61P 27/10
A61P 31/14
A61P 31/16
A61P 31/20
A61P 31/18
C12N 5/09
C12N 5/071
C07H 19/056
A61K 31/7056
C07F 7/10
A61K 31/695
A61P 17/10
C07D 471/04
US Classification:
514 43, 546 85, 544361, 544126, 544331, 544319, 514292, 51425303, 5142328, 514275, 514269, 544 586, 5142282, 544122, 544212, 514245, 544405, 51425505, 435366, 435375, 546 87, 536 287, 544182, 514242, 546 14, 514 63
Abstract:
Compounds that selectively inhibit pathological production of human vascular endothelial growth factor (VEGF) and compositions comprising such Compounds are described. Compounds that inhibit viral replication or the production of viral RNA or DNA or viral protein and compositions comprising such Compounds are described. Also described are methods of reducing VEGF using such Compounds and methods for treating cancer and non-neoplastic conditions involving the administration of such Compounds. Further described are methods of inhibiting viral replication or the production of viral RNA or DNA or viral protein using such Compounds and methods for treating viral infections involving the administration of such Compounds. The Compounds may be administered as a single agent therapy or in combination with one or more additional therapies to a human in need of such treatments.

Methods For Treating Breast Cancer

View page
US Patent:
20120202801, Aug 9, 2012
Filed:
May 27, 2010
Appl. No.:
13/321271
Inventors:
Thomas W. Davis - South Orange NJ, US
Samit Hirawat - Chatham NJ, US
Harry H. Miao - Wellesley MA, US
Langdon Miller - Seattle WA, US
Charles M. Romfo - Easton PA, US
Marla L. Weetall - Morristown NJ, US
International Classification:
A61K 31/541
A61K 31/496
A61K 31/5377
A61K 31/4375
A61P 35/00
US Classification:
5142282, 514292, 5142328, 51425303
Abstract:
Methods for treating breast cancer involving the administration of a compound that selectively inhibits pathological production of human vascular endothelial growth factor (VEGF) are described. The compound can be administered as a single agent therapy or in combination with one or more additional therapies to a human in need of such treatment.

Antagonists Of Neuropilin Receptor Function And Use Thereof

View page
US Patent:
20140056872, Feb 27, 2014
Filed:
Oct 29, 2012
Appl. No.:
13/662588
Inventors:
Shay Soker - Greensboro NC, US
Harry Hua-Quan Miao - Edison NJ, US
Seiji Takashima - Osaka, JP
Assignee:
CHILDREN'S MEDICAL CENTER CORPORATION - Boston MA
International Classification:
A61K 39/395
C07K 16/28
US Classification:
4241331, 4241391, 5303879
Abstract:
The present invention relates to antagonists of neuropilin receptor function and use thereof in the treatment of cancer, particularly metastatic cancer, and angiogenic diseases.

Antagonists Of Neuropilin Receptor Function And Use Thereof

View page
US Patent:
20110002919, Jan 6, 2011
Filed:
Mar 17, 2010
Appl. No.:
12/726171
Inventors:
Michael Klagsbrun - Newton MA, US
Shay Soker - Greensboro NC, US
Harry Hua-Quan Miao - Edison NJ, US
Seiji Takashima - Osaka, JP
Assignee:
Children's Medical Center - Boston MA
International Classification:
A61K 39/395
C07K 16/28
A61P 35/04
US Classification:
4241331, 4241391, 5303879, 4241721
Abstract:
The present invention relates to antagonists of neuropilin receptor fuction and use thereof in the treatment of cancer, particularly metastatic cancer, and angiogenic diseases.

Antagonists Of Neuropilin Receptor Function And Use Thereof

View page
US Patent:
20150025224, Jan 22, 2015
Filed:
Oct 1, 2014
Appl. No.:
14/503991
Inventors:
- Boston MA, US
Shay Soker - Greensboro NC, US
Harry Hua-Quan Miao - Edison NJ, US
Seiji Takashima - Osaka, JP
International Classification:
C07K 16/28
US Classification:
5303871
Abstract:
The present invention relates to antagonists of neuropilin receptor function and use thereof in the treatment of cancer, particularly metastatic cancer, and angiogenic diseases.
Control profile
Harry H Miao from Redondo Beach, CA, age ~61 Get Report